Skip to main content

Castleman’s disease



Background and Aims

Castleman’s disease is a rare disease of lymph node with two identified forms — the hyaline vascular type or angiofollicular type and plasma cell type. It usually presents as localized or systemic lymphadenopathy or even as extra nodal mass and may give rise to several differential diagnoses. Fine needle aspiration cytology (FNAC), as the initial investigation, may be misleading. Excision biopsy usually gives the diagnosis.

Materials and Methods

We report a case of an 8 year old male child who was Presented with a history of a slowly growing mass in his right side of neck for 3 yrs. He Was largely asymptomatic except for occasional discomfort around the mass. His past medical and family history was non-specific. On examination a non-tender, firm mass Was palpated. Initially Clinically suspected to be lymphoma, but was later histologically confirmed to have Castleman’s disease.


We had one case of Castleman’s disease which presented as cervical lymphadenopathy of 3 FNx01 2 cms in 8 year child. Patient was mostly asymptomatic with all relevant investigations within normal limits. The cytology findings mostly showed a predominance of small lymphocytes with capillary fragments. On excision biopsy, the case was diagnosed as Castleman’s disease of the hyaline vascular type.


Castleman’s disease should be kept as a differential of lymphadenopathy, especially in asymptomatic and young patients.


  1. Castleman B, Iverson I, Menendez VP. Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer 1956; 9: 822–830.

    Article  CAS  Google Scholar 

  2. Gaba AR, Stein RS, Sweet DL, Variakojis D. Multicentric giant lymph node hyperplasia. Am J Clin Pathol 1978; 69: 86–90.

    Article  CAS  Google Scholar 

  3. McCarty MJ, Svetislava JV, Banks PM. Angiofollicular lymph node hyperplasia (Castleman’s disease). Cancer Treat Rev 1995; 21: 291–310.

    Article  CAS  Google Scholar 

  4. Talat N, Schulte KM. Castleman’s disease: systematic analysis of 416 patients from the literature. Oncologist 2011; 16: 1316.

    Article  Google Scholar 

  5. Roca B. Castleman’s disease. A review. AIDS Rev 2009; 11: 3.

    PubMed  Google Scholar 

  6. Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol 2005; 129: 3.

    Article  Google Scholar 

  7. Schulte KM, Talat N. Castleman’s disease — a two compartment model of HHV8 infection. Nat Rev Clin Oncol 2010; 7: 533.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Ashraf A. Kasem MB.Ch B, MS, MRCS (ENT) (Glasg) DO-HNS (Glasg).

Additional information

Conflicts of interest

None declared.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kasem, A.A., Al Thubaity, T. Castleman’s disease. Egypt J Otolaryngol 30, 371–373 (2014).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: